- Type / Class
- Equity / Common Stock
- Shares outstanding
- 39,581,465
- Total 13F shares
- 35,567,022
- Share change
- -170,918
- Total reported value
- $471,619,624
- Put/Call ratio
- 3600%
- Price per share
- $13.26
- Number of holders
- 129
- Value change
- -$3,810,664
- Number of buys
- 65
- Number of sells
- 69
Quarterly Holders Quick Answers
What is CUSIP 68752M108?
CUSIP 68752M108 identifies OFIX - Orthofix Medical Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68752M108:
Top shareholders of OFIX - Orthofix Medical Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
9.3%
|
3,700,000
|
$53,724,000 | — | 31 Mar 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
9.3%
|
3,665,000
|
$53,215,800 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.3%
|
3,293,230
|
$47,817,700 | — | 31 Mar 2024 | |
| Engine Capital Management, LP |
13F
|
Company |
7.7%
|
3,035,301
|
$44,072,571 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
mixed-class rows
|
2,762,197
mixed-class rows
|
$40,072,874 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.1%
|
2,008,816
|
$29,168,009 | — | 31 Mar 2024 | |
| PARADIGM CAPITAL MANAGEMENT INC/NY |
13F
|
Company |
4.9%
|
1,946,963
|
$28,269,903 | — | 31 Mar 2024 | |
| Newtyn Management, LLC |
13F
|
Company |
3.2%
|
1,271,473
|
$18,461,788 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
1,067,108
|
$15,494,408 | — | 31 Mar 2024 | |
| BOONE CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.5%
|
974,502
|
$14,149,769 | — | 31 Mar 2024 | |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
883,125
|
$12,822,975 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
mixed-class rows
|
903,775
mixed-class rows
|
$11,780,313 | — | 31 Mar 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
1.9%
|
765,204
|
$11,110,755 | — | 31 Mar 2024 | |
| AYAL Capital Advisors Ltd |
13F
|
Company |
1.6%
|
623,097
|
$9,047,368 | — | 31 Mar 2024 | |
| AWM Investment Company, Inc. |
13F
|
Company |
1.2%
|
474,456
|
$6,889,101 | — | 31 Mar 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
1.1%
|
434,711
|
$6,312,004 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
433,748
|
$6,298,021 | — | 31 Mar 2024 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
1%
|
394,662
|
$5,730,498 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.99%
|
391,327
|
$5,682,068 | — | 31 Mar 2024 | |
| Keith Valentine |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
377,741
|
$5,156,165 | — | 28 Feb 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.89%
|
353,214
|
$5,128,668 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.87%
|
342,642
|
$4,975,161 | — | 31 Mar 2024 | |
| Jon Carl Serbousek |
3/4/5
|
Executive Chairman, Director |
—
class O/S missing
|
346,827
|
$4,734,189 | — | 03 Apr 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.72%
|
283,622
|
$4,118,191 | — | 31 Mar 2024 | |
| Clearline Capital LP |
13F
|
Company |
0.65%
|
259,194
|
$3,763,497 | — | 31 Mar 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.65%
|
257,537
|
$3,739,437 | — | 31 Mar 2024 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.57%
|
225,636
|
$3,276,234 | — | 31 Mar 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.56%
|
221,309
|
$3,213,411 | — | 31 Mar 2024 | |
| AREX Capital Management, LP |
13F
|
Company |
0.56%
|
220,000
|
$3,194,400 | — | 31 Mar 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.55%
|
215,760
|
$3,133,000 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.53%
|
210,892
|
$3,062,152 | — | 31 Mar 2024 | |
| Kimberley A. Elting |
3/4/5
|
President, Global Orthopedics |
—
mixed-class rows
|
271,614
mixed-class rows
|
$3,056,365 | — | 08 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.53%
|
209,817
|
$3,046,543 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
198,895
|
$2,887,955 | — | 31 Mar 2024 | |
| Stuart Essig |
3/4/5
|
Director |
—
class O/S missing
|
205,966
|
$2,811,436 | — | 05 Jan 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.48%
|
191,554
|
$2,781,365 | — | 31 Mar 2024 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.44%
|
175,671
|
$2,550,743 | — | 31 Mar 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.42%
|
167,900
|
$2,437,908 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.4%
|
157,777
|
$2,290,922 | — | 31 Mar 2024 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
0.38%
|
149,200
|
$2,166,384 | — | 31 Mar 2024 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.37%
|
146,000
|
$2,119,920 | — | 31 Mar 2024 | |
| Kevin J. Kenny |
3/4/5
|
President of Global Spine |
—
class O/S missing
|
145,810
|
$1,990,307 | — | 08 Jan 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.34%
|
134,654
|
$1,955,183 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
—
mixed-class rows
|
141,074
mixed-class rows
|
$1,887,878 | — | 31 Mar 2024 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
0.31%
|
122,690
|
$1,781,459 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.3%
|
117,536
|
$1,707,000 | — | 31 Mar 2024 | |
| Catherine M. Burzik |
3/4/5
|
Director |
—
class O/S missing
|
112,803
|
$1,605,187 | — | 08 Apr 2024 | |
| Rice Doug |
3/4/5
|
CFO |
—
class O/S missing
|
107,679
|
$1,469,818 | — | 11 Apr 2022 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.24%
|
95,797
|
$1,390,972 | — | 31 Mar 2024 | |
| John J. Bostjancic |
3/4/5
|
CFO |
—
class O/S missing
|
99,670
|
$1,360,496 | — | 28 Feb 2023 |
Institutional Holders of Orthofix Medical Inc. - Common Stock (OFIX) as of Q2 2024
As of 30 Jun 2024,
Orthofix Medical Inc. - Common Stock (OFIX) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,567,022 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Rubric Capital Management LP, Engine Capital Management, LP, BlackRock Inc., PARADIGM CAPITAL MANAGEMENT INC/NY, VANGUARD GROUP INC, MORGAN STANLEY, Newtyn Management, LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
129
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
136
Q2 2024 holders
129
Holder diff
-7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.